With the adoption of the new Sustainable Development Goals in 2016, all countries have committed to end the tuberculosis (TB) epidemic by 2030, defined as dramatic reductions in TB incidence and mortality combined with zero TB-induced catastrophic costs for families.
This paper explores how antiretroviral therapy (ART) in high HIV-TB burden countries may help in reducing TB incidence and mortality and thus contribute to the ambitious goal of ending TB. ART in people living with HIV has a potent TB preventive effect, with this being most apparent in those with the most advanced immunodeficiency.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Anthony D Harries, Ajay MV Kumar, Nang Thu Thu Kyaw, Nguyen Binh Hoa, Kudakwashe C Takarinda, Rony Zachariah. The role of antiretroviral therapy in reducing TB incidence and mortality in high HIV-TB burden countries. Asian Pacific Journal of Tropical Disease
Volume 6, Issue 3, March 2016, Pages 243-247 https://doi.org/10.1016/S2222-1808(15)61023-4
The role of antiretroviral therapy in reducing TB incidence and mortality in high HIV-TB burden countries Subcription or payment maybe required to access